TickerFactsScreenerDevelopers

aTYR PHARMA INC (ATYR) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $3.67M2013: $36.46M2014: $13.90M2015: $53.02M2016: $38.39M2017: $21.09M2018: $22.96M2019: $9.21M2020: $16.95M2021: $2.34M2022: $9.98M2023: $22.54M2024: $11.05M2025: $10.74M$10.74M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$10.74M-2.8%
2024$11.05M-51.0%
2023$22.54M+125.9%
2022$9.98M+327.3%
2021$2.34M-86.2%
2020$16.95M+84.1%
2019$9.21M-59.9%
2018$22.96M+8.9%
2017$21.09M-45.1%
2016$38.39M-27.6%
2015$53.02M+281.5%
2014$13.90M-61.9%
2013$36.46M+892.0%
2012$3.67M—